Novartis Interested in Expanding Globally in Vaccines, FuW Says
By Eva von Schaper -
2010-12-01T09:23:57Z
Novartis AG’s vaccine unit is interested in acquisitions that enable global expansion rather those that provide new products, Finanz und Wirtschaft said, citing an interview with the unit’s head, Andrin Oswald.
The size of a possible acquisition could be between $100 million and $200 million, the newspaper cited Oswald as saying. Novartis doesn’t need to buy vaccine products because it has a full pipeline, Oswald is quoted as saying in the newspaper.
To contact the reporter on this story: Eva von Schaper in Munich at evonschaper@bloomberg.net;
To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net.
Sponsored Link
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.